A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Clinical trial NCT04176198 · RECRUITING
Trial details
- NCT number
- NCT04176198
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2027-04-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.